{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T00:39:40Z","timestamp":1768437580877,"version":"3.49.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T00:00:00Z","timestamp":1359676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Pharmaceutics"],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1016\/j.ijpharm.2012.12.035","type":"journal-article","created":{"date-parts":[[2013,1,3]],"date-time":"2013-01-03T08:03:15Z","timestamp":1357200195000},"page":"80-86","source":"Crossref","is-referenced-by-count":42,"title":["A nontoxic disulfide bond reducing method for lipophilic drug-loaded albumin nanoparticle preparation: Formation dynamics, influencing factors and formation mechanisms investigation"],"prefix":"10.1016","volume":"443","author":[{"given":"Liqun","family":"Jiang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yisheng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liang","family":"Ge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunli","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiabi","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianping","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpharm.2012.12.035_bib0005","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1007\/s10895-010-0781-3","article-title":"pH-induced conformational isomerization of bovine serum albumin studied by extrinsic and intrinsic protein fluorescence","volume":"21","author":"Bhattacharya","year":"2011","journal-title":"J. Fluoresc."},{"key":"10.1016\/j.ijpharm.2012.12.035_bib0010","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.molstruc.2004.05.026","article-title":"Investigation of the interaction between flavonoids and human serum albumin","volume":"703","author":"Bi","year":"2004","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.ijpharm.2012.12.035_bib0015","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/sj.embor.7400645","article-title":"The role of glutathione in disulphide bond formation and endoplasmic-reticulum-generated oxidative stress","volume":"7","author":"Chakravarthi","year":"2006","journal-title":"EMBO Rep."},{"key":"10.1016\/j.ijpharm.2012.12.035_bib0020","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.jconrel.2004.03.013","article-title":"Hydrotropic agents for study of in vitro paclitaxel release from polymeric micells","volume":"97","author":"Cho","year":"2004","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2012.12.035_bib0025","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/1477-3155-10-36","article-title":"Engineering of near IR fluorescent albumin nanoparticles for in vivo detection of colon cancer","volume":"10","author":"Cohen","year":"2012","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.ijpharm.2012.12.035_bib0030","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/B978-0-12-391858-1.00008-3","article-title":"Targeting nanoparticles to dendritic cells for immunotherapy","volume":"509","author":"Cruz","year":"2012","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.ijpharm.2012.12.035_bib0035","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.jconrel.2011.07.031","article-title":"Albumin-based nanoparticles as potential controlled release drug delivery systems","volume":"157","author":"Elzoghby","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2012.12.035_bib0040","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1002\/smll.200901689","article-title":"Bovine serum albumin-based magnetic nanocarrier for MRI diagnosis and hyperthermic therapy: a potential theranostic approach against cancer","volume":"6","author":"Franchini","year":"2010","journal-title":"Small"},{"key":"10.1016\/j.ijpharm.2012.12.035_bib0045","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1021\/bm201401s","article-title":"Molecular switch for the assembly of lipophilic drug incorporated plasma protein nanoparticles and in vivo image","volume":"13","author":"Gong","year":"2011","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.ijpharm.2012.12.035_bib0050","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1088\/0957-4484\/22\/29\/295603","article-title":"Fabrication of a nanocarrier system through self-assembly of plasma protein and its tumor targeting","volume":"22","author":"Gong","year":"2011","journal-title":"Nanotechnology"},{"key":"10.1016\/j.ijpharm.2012.12.035_bib0055","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.ijpharm.2009.04.033","article-title":"Synthesis, characterization, drug-loading capacity and safety of novel octyl modified serum albumin micells","volume":"376","author":"Gong","year":"2009","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2012.12.035_bib0060","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.ijpharm.2011.08.052","article-title":"PEGylated poly(trimethylene carbonate) nanoparticles loaded with paclitaxel for the treatment of advanced glioma: in vitro and in vivo evaluation","volume":"420","author":"Jiang","year":"2011","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2012.12.035_bib0065","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.ijpharm.2007.08.001","article-title":"Preparation and characterization of sodium ferulate entrapped bovine serum albumin nanoparticles for liver targeting","volume":"349","author":"Li","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2012.12.035_bib0070","first-page":"397","article-title":"Preparation, characterization and targeting of micronized 10-hydroxycamptothecin-loaded folate-conjugated human serum albumin nanoparticles to cancer cells","volume":"6","author":"Li","year":"2011","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.ijpharm.2012.12.035_bib0075","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jconrel.2006.11.015","article-title":"Brain delivery property and accelerated blood clearance of cationic albumin conjugated pegylated nanoparticle","volume":"118","author":"Lu","year":"2007","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2012.12.035_bib0080","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1002\/jbm.a.34051","article-title":"Tamoxifen-loaded thiolated alginate-albumin nanoparticles as antitumoral drug delivery systems","volume":"100","author":"Mart\u00ednez","year":"2012","journal-title":"J. Biomed. Mater. Res. A"},{"key":"10.1016\/j.ijpharm.2012.12.035_bib0085","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0168-1656(00)00242-X","article-title":"BSA structural changes during homomolecular exchange between the adsorbed and the dissolved states","volume":"79","author":"Norde","year":"2000","journal-title":"J. Biotechnol."},{"key":"10.1016\/j.ijpharm.2012.12.035_bib0090","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.saa.2012.02.038","article-title":"Spectral characterization of the binding and conformational changes of serum albumins upon interaction with an anticancer drug, anastrozole","volume":"92","author":"Punith","year":"2012","journal-title":"Spectrochim. Acta A: Mol. Biomol. Spectrosc."},{"key":"10.1016\/j.ijpharm.2012.12.035_bib0095","first-page":"16","article-title":"The clinical pharmacology of pacitaxel (Taxol)","volume":"20","author":"Rowinsky","year":"1993","journal-title":"Semin. Oncol."},{"key":"10.1016\/j.ijpharm.2012.12.035_bib0100","doi-asserted-by":"crossref","first-page":"138","DOI":"10.3109\/02652048.2011.635218","article-title":"Albumin nanoparticles with predictable size by desolvation procedure","volume":"29","author":"Storp","year":"2012","journal-title":"J. Microencapsulation"},{"key":"10.1016\/j.ijpharm.2012.12.035_bib0105","doi-asserted-by":"crossref","first-page":"4207","DOI":"10.1039\/c1lc20809h","article-title":"Microchip integrating magnetic nanoparticles for allergy diagnosis","volume":"11","author":"Teste","year":"2011","journal-title":"Lab Chip"},{"key":"10.1016\/j.ijpharm.2012.12.035_bib0110","doi-asserted-by":"crossref","first-page":"447","DOI":"10.2217\/nnm.12.10","article-title":"Nanoparticles for cancer therapy using magnetic forces","volume":"7","author":"Tietze","year":"2012","journal-title":"Nanomedicine (Lond)"},{"key":"10.1016\/j.ijpharm.2012.12.035_bib0115","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.jinorgbio.2010.10.018","article-title":"New advances in the study on the interaction of [Cr(phen)2(dppz)]3+ complex with biological models; association to transporting proteins","volume":"105","author":"Toneatto","year":"2011","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.ijpharm.2012.12.035_bib0120","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1590\/S0100-879X2008000700007","article-title":"Spectroscopic studies on the interaction of efonidipine with bovine serum albumin","volume":"41","author":"Wang","year":"2008","journal-title":"Braz. J. Med. Biol. Res."},{"key":"10.1016\/j.ijpharm.2012.12.035_bib0125","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.jpba.2007.08.032","article-title":"Analysis of binding interaction between puerarin and bovine serum albumin by multi-spectroscopic method","volume":"45","author":"Xiao","year":"2007","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.ijpharm.2012.12.035_bib0130","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ijpharm.2007.03.028","article-title":"Preparation, characterization and biodistribution of the lactone form of 10-hydroxycamptothecin (HCPT)-loaded bovine serum albumin (BSA) nanoparticles","volume":"340","author":"Yang","year":"2007","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2012.12.035_bib0135","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1007\/s11095-012-0679-7","article-title":"Magnetic nanoparticles for cancer diagnosis and therapy","volume":"29","author":"Yigit","year":"2012","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2012.12.035_bib0140","doi-asserted-by":"crossref","first-page":"528","DOI":"10.3109\/02652048.2011.590614","article-title":"Preparation of the albumin nanoparticle system loaded with both paclitaxel and sorafenib and its evaluation in vitro and in vivo","volume":"28","author":"Zhang","year":"2011","journal-title":"J. Microencapsulation"},{"key":"10.1016\/j.ijpharm.2012.12.035_bib0145","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/j.scitotenv.2010.11.004","article-title":"The interaction between Ag+ and bovine serum albumin: a spectroscopic investigation","volume":"409","author":"Zhao","year":"2011","journal-title":"Sci. Total Environ."}],"container-title":["International Journal of Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517312011076?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517312011076?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,19]],"date-time":"2018-10-19T19:29:24Z","timestamp":1539977364000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378517312011076"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2]]},"references-count":29,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2013,2]]}},"alternative-id":["S0378517312011076"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpharm.2012.12.035","relation":{},"ISSN":["0378-5173"],"issn-type":[{"value":"0378-5173","type":"print"}],"subject":[],"published":{"date-parts":[[2013,2]]}}}